Redefining Translational Medicine through Veterinary Clinical Trials

Redefining Translational Medicine through Veterinary Clinical Trials

July 17, 2018


727 E. Tyler St.
Tempe, AZ 85281


Biodesign Institute, Auditorium

Date and Time

August 2, 2018, 12:00 pm (Length: 1 hour 0 minutes)

iCal Download

Craig Woods, DVM, MBA, Director, Institute for Healthcare Innovation, Assistant Professor, Midwestern University

Translational medicine is being redefined; away from inducing disease in lab animals and toward the study of spontaneous diseases in companion animals. Companion animals develop orthopedic, neoplastic, neurological, immune-mediated, genetic and infectious diseases with comparable pathophysiology to people. In addition, veterinary medicine offers a real-world hospital setting and a diverse translational population to evaluate medical technologies for researchers, startup companies and university technology transfer offices. This seminar will cover comparative diseases in orthopedics, neurology and infectious disease; how to leverage veterinary trials to de-risk technologies and increase technology valuation; and reveal development considerations for entering the multibillion-dollar animal health market.